Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
bcl-2-Associated X Protein | 27 | 2024 | 283 | 8.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 29 | 2024 | 1409 | 5.620 |
Why?
|
Apoptosis | 44 | 2024 | 9512 | 3.850 |
Why?
|
Peptides | 30 | 2022 | 4331 | 3.840 |
Why?
|
Proto-Oncogene Proteins | 17 | 2020 | 4521 | 2.340 |
Why?
|
Hydrocarbons | 6 | 2016 | 105 | 2.270 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 8 | 2015 | 70 | 1.990 |
Why?
|
Apoptosis Regulatory Proteins | 9 | 2022 | 1150 | 1.760 |
Why?
|
Minor Histocompatibility Antigens | 5 | 2020 | 303 | 1.580 |
Why?
|
Protein Structure, Secondary | 16 | 2018 | 1210 | 1.530 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 8 | 2013 | 88 | 1.260 |
Why?
|
Mitochondria | 18 | 2024 | 3670 | 1.240 |
Why?
|
Models, Molecular | 20 | 2024 | 5377 | 1.230 |
Why?
|
Cysteine | 4 | 2024 | 898 | 1.140 |
Why?
|
Tumor Suppressor Protein p53 | 9 | 2020 | 2945 | 1.140 |
Why?
|
Small Molecule Libraries | 4 | 2019 | 741 | 1.130 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 4 | 2024 | 89 | 1.100 |
Why?
|
Protein Binding | 26 | 2024 | 9297 | 1.070 |
Why?
|
Protein Structure, Tertiary | 14 | 2015 | 3749 | 1.070 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 4 | 2020 | 360 | 1.030 |
Why?
|
Lipopeptides | 1 | 2024 | 73 | 0.870 |
Why?
|
Molecular Dynamics Simulation | 2 | 2024 | 422 | 0.850 |
Why?
|
Amino Acid Sequence | 25 | 2024 | 13402 | 0.840 |
Why?
|
Binding Sites | 15 | 2021 | 5999 | 0.830 |
Why?
|
Acyl-CoA Dehydrogenase, Long-Chain | 2 | 2022 | 49 | 0.790 |
Why?
|
Antineoplastic Agents | 10 | 2023 | 13635 | 0.760 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2022 | 120 | 0.760 |
Why?
|
Disulfides | 2 | 2020 | 462 | 0.740 |
Why?
|
Protein Multimerization | 3 | 2021 | 959 | 0.730 |
Why?
|
Membrane Proteins | 17 | 2015 | 7846 | 0.710 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2020 | 84 | 0.690 |
Why?
|
Protein Conformation | 9 | 2021 | 3945 | 0.670 |
Why?
|
Mitochondrial Membranes | 1 | 2020 | 184 | 0.630 |
Why?
|
Structure-Activity Relationship | 8 | 2020 | 3053 | 0.630 |
Why?
|
Mitochondrial Diseases | 1 | 2022 | 344 | 0.610 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2022 | 373 | 0.600 |
Why?
|
Peptide Fragments | 7 | 2017 | 5127 | 0.600 |
Why?
|
Apoproteins | 1 | 2017 | 45 | 0.600 |
Why?
|
Cytosol | 3 | 2021 | 885 | 0.590 |
Why?
|
Cell Death | 4 | 2019 | 1678 | 0.590 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 17063 | 0.580 |
Why?
|
Neuroprotective Agents | 1 | 2024 | 958 | 0.570 |
Why?
|
Phenyl Ethers | 1 | 2017 | 62 | 0.570 |
Why?
|
Palmitic Acid | 1 | 2018 | 147 | 0.560 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2019 | 348 | 0.560 |
Why?
|
Animals | 73 | 2024 | 168730 | 0.560 |
Why?
|
Peritonitis | 1 | 2019 | 368 | 0.550 |
Why?
|
Neuropeptides | 11 | 2003 | 951 | 0.540 |
Why?
|
Mice | 46 | 2024 | 81788 | 0.530 |
Why?
|
Protein Unfolding | 2 | 2014 | 57 | 0.530 |
Why?
|
Proteomics | 5 | 2023 | 3909 | 0.520 |
Why?
|
Cytoskeletal Proteins | 11 | 2003 | 1322 | 0.520 |
Why?
|
Drug Design | 5 | 2020 | 1040 | 0.510 |
Why?
|
Allosteric Regulation | 2 | 2016 | 425 | 0.490 |
Why?
|
Ubiquitin | 1 | 2020 | 839 | 0.490 |
Why?
|
Peptides, Cyclic | 2 | 2018 | 390 | 0.490 |
Why?
|
Amino Acids | 1 | 2021 | 1709 | 0.480 |
Why?
|
Cell Cycle Proteins | 5 | 2020 | 3430 | 0.480 |
Why?
|
SOS1 Protein | 1 | 2015 | 40 | 0.480 |
Why?
|
bcl-X Protein | 4 | 2017 | 414 | 0.470 |
Why?
|
Molecular Sequence Data | 18 | 2015 | 17595 | 0.470 |
Why?
|
Oligopeptides | 1 | 2020 | 1193 | 0.460 |
Why?
|
Mitochondria, Liver | 2 | 2013 | 190 | 0.450 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1313 | 0.450 |
Why?
|
Viral Fusion Proteins | 1 | 2014 | 100 | 0.440 |
Why?
|
Nose Diseases | 1 | 2014 | 78 | 0.430 |
Why?
|
Cross-Linking Reagents | 2 | 2014 | 687 | 0.430 |
Why?
|
Cell Line | 11 | 2020 | 15540 | 0.420 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2014 | 168 | 0.420 |
Why?
|
Mass Spectrometry | 3 | 2015 | 2194 | 0.410 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2014 | 306 | 0.410 |
Why?
|
Cyclin D1 | 1 | 2013 | 449 | 0.380 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2418 | 0.380 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2018 | 3641 | 0.380 |
Why?
|
Nuclear Proteins | 5 | 2016 | 5781 | 0.380 |
Why?
|
Molecular Mimicry | 3 | 2017 | 210 | 0.370 |
Why?
|
Protein Interaction Mapping | 2 | 2018 | 619 | 0.370 |
Why?
|
Aldehydes | 2 | 2024 | 169 | 0.360 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2013 | 238 | 0.360 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 230 | 0.350 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1137 | 0.350 |
Why?
|
Biomedical Research | 2 | 2024 | 3457 | 0.350 |
Why?
|
Molecular Structure | 3 | 2020 | 1886 | 0.340 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 1166 | 0.340 |
Why?
|
HIV Fusion Inhibitors | 1 | 2010 | 82 | 0.340 |
Why?
|
Humans | 82 | 2024 | 765823 | 0.330 |
Why?
|
Aniline Compounds | 2 | 2013 | 1075 | 0.330 |
Why?
|
ras Proteins | 1 | 2015 | 1054 | 0.330 |
Why?
|
Fibroblasts | 3 | 2016 | 4160 | 0.330 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1892 | 0.330 |
Why?
|
Photosensitizing Agents | 1 | 2014 | 626 | 0.320 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2014 | 365 | 0.320 |
Why?
|
Cytochromes c | 5 | 2013 | 173 | 0.320 |
Why?
|
Lipids | 2 | 2020 | 3316 | 0.320 |
Why?
|
Bacteria | 1 | 2019 | 2209 | 0.300 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1489 | 0.290 |
Why?
|
High-Throughput Screening Assays | 2 | 2015 | 938 | 0.290 |
Why?
|
HIV Antibodies | 1 | 2014 | 1337 | 0.290 |
Why?
|
HEK293 Cells | 6 | 2021 | 4255 | 0.290 |
Why?
|
Crystallography, X-Ray | 4 | 2018 | 1945 | 0.280 |
Why?
|
Glucose | 5 | 2022 | 4332 | 0.280 |
Why?
|
Erythrocyte Membrane | 5 | 1999 | 428 | 0.270 |
Why?
|
Receptors, Odorant | 2 | 1998 | 67 | 0.260 |
Why?
|
Testicular Neoplasms | 1 | 2012 | 800 | 0.260 |
Why?
|
Cell Survival | 9 | 2020 | 5747 | 0.260 |
Why?
|
Coronavirus Infections | 1 | 2024 | 3099 | 0.260 |
Why?
|
Sex Factors | 1 | 2020 | 10607 | 0.260 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2020 | 10723 | 0.250 |
Why?
|
Liposomes | 4 | 2020 | 787 | 0.250 |
Why?
|
Drosophila Proteins | 1 | 2015 | 1697 | 0.250 |
Why?
|
Sulfonamides | 2 | 2013 | 1981 | 0.250 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2018 | 390 | 0.250 |
Why?
|
Sepsis | 1 | 2019 | 2603 | 0.240 |
Why?
|
Recombinant Proteins | 6 | 2020 | 6489 | 0.240 |
Why?
|
Neural Stem Cells | 1 | 2012 | 897 | 0.240 |
Why?
|
Signal Transduction | 8 | 2021 | 23588 | 0.240 |
Why?
|
Oxidation-Reduction | 3 | 2021 | 2219 | 0.240 |
Why?
|
Pyruvate Carboxylase | 2 | 2021 | 17 | 0.240 |
Why?
|
Mutation | 9 | 2021 | 30188 | 0.240 |
Why?
|
Alkenes | 1 | 2004 | 54 | 0.230 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 2010 | 0.230 |
Why?
|
Neoplasms | 7 | 2022 | 22349 | 0.230 |
Why?
|
Caspase 7 | 3 | 2015 | 51 | 0.230 |
Why?
|
Leukemia, Experimental | 1 | 2004 | 224 | 0.230 |
Why?
|
Jurkat Cells | 5 | 2013 | 737 | 0.220 |
Why?
|
Insulin-Secreting Cells | 3 | 2020 | 898 | 0.220 |
Why?
|
Cell Membrane Permeability | 2 | 2020 | 562 | 0.220 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3677 | 0.210 |
Why?
|
Mice, Knockout | 7 | 2021 | 14445 | 0.200 |
Why?
|
bcl-Associated Death Protein | 2 | 2015 | 102 | 0.190 |
Why?
|
Caspase 3 | 3 | 2015 | 731 | 0.190 |
Why?
|
Drug Discovery | 2 | 2020 | 1063 | 0.190 |
Why?
|
Axons | 2 | 2021 | 1678 | 0.180 |
Why?
|
Cloning, Molecular | 5 | 2017 | 4165 | 0.180 |
Why?
|
Spermatids | 2 | 1998 | 36 | 0.180 |
Why?
|
Tacrolimus Binding Proteins | 3 | 1998 | 199 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1644 | 0.170 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4779 | 0.170 |
Why?
|
Protein Transport | 3 | 2013 | 1937 | 0.170 |
Why?
|
Axonal Transport | 1 | 2021 | 178 | 0.170 |
Why?
|
Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.170 |
Why?
|
Endoplasmic Reticulum | 3 | 2016 | 1132 | 0.170 |
Why?
|
Enzyme Activation | 4 | 2015 | 3585 | 0.170 |
Why?
|
Osteosarcoma | 2 | 2016 | 909 | 0.170 |
Why?
|
Sperm Motility | 2 | 1998 | 264 | 0.170 |
Why?
|
Testis | 3 | 1998 | 781 | 0.160 |
Why?
|
Molecular Conformation | 1 | 2020 | 541 | 0.160 |
Why?
|
Glutathione | 1 | 2021 | 589 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5335 | 0.160 |
Why?
|
Immunophilins | 1 | 1998 | 20 | 0.160 |
Why?
|
Glucokinase | 3 | 2015 | 98 | 0.160 |
Why?
|
COS Cells | 5 | 2016 | 1135 | 0.150 |
Why?
|
Inositol 1,4,5-Trisphosphate | 2 | 1995 | 110 | 0.150 |
Why?
|
Genitalia, Male | 1 | 1998 | 87 | 0.150 |
Why?
|
Membranes, Artificial | 1 | 2020 | 362 | 0.150 |
Why?
|
Serine | 1 | 2022 | 824 | 0.150 |
Why?
|
Tryptophan | 1 | 2020 | 483 | 0.150 |
Why?
|
Muscular Diseases | 1 | 2022 | 550 | 0.150 |
Why?
|
Urea | 1 | 2020 | 449 | 0.150 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2012 | 499 | 0.140 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9241 | 0.140 |
Why?
|
Ligands | 2 | 2017 | 3273 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2020 | 576 | 0.140 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2017 | 446 | 0.140 |
Why?
|
Biological Transport | 3 | 2020 | 2082 | 0.140 |
Why?
|
Hydrazones | 1 | 2017 | 105 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6943 | 0.140 |
Why?
|
Dimerization | 2 | 2016 | 880 | 0.140 |
Why?
|
Oxidative Stress | 3 | 2021 | 3139 | 0.140 |
Why?
|
Rhabdoid Tumor | 1 | 2019 | 209 | 0.140 |
Why?
|
Transcription, Genetic | 4 | 2018 | 7599 | 0.130 |
Why?
|
Arginine | 1 | 2020 | 933 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2017 | 3604 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2014 | 3222 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8601 | 0.130 |
Why?
|
Acrosome | 1 | 1995 | 9 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 996 | 0.130 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1739 | 0.120 |
Why?
|
Circular Dichroism | 3 | 2018 | 332 | 0.120 |
Why?
|
Deuterium Exchange Measurement | 1 | 2015 | 31 | 0.120 |
Why?
|
Escherichia coli | 3 | 2017 | 4211 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1624 | 0.120 |
Why?
|
Research Personnel | 1 | 2020 | 590 | 0.120 |
Why?
|
Sequence Alignment | 4 | 2008 | 2171 | 0.120 |
Why?
|
Neoplasm Transplantation | 2 | 2012 | 2011 | 0.120 |
Why?
|
Calcium Channels | 2 | 1995 | 622 | 0.120 |
Why?
|
Arrestins | 1 | 1995 | 73 | 0.120 |
Why?
|
Spermatozoa | 2 | 1998 | 629 | 0.120 |
Why?
|
Phosphoproteins | 2 | 2013 | 2444 | 0.120 |
Why?
|
Fatty Acids | 1 | 2022 | 1806 | 0.120 |
Why?
|
Anti-HIV Agents | 1 | 2010 | 4558 | 0.110 |
Why?
|
Chromatography, Gel | 1 | 2015 | 629 | 0.110 |
Why?
|
Protein Engineering | 2 | 2010 | 550 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2020 | 1999 | 0.110 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 1995 | 852 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2022 | 11888 | 0.110 |
Why?
|
Ceramides | 1 | 2015 | 201 | 0.110 |
Why?
|
Alternative Splicing | 2 | 1999 | 1106 | 0.110 |
Why?
|
Rats | 12 | 2021 | 23707 | 0.110 |
Why?
|
Cells, Cultured | 6 | 2021 | 18970 | 0.110 |
Why?
|
Mice, Nude | 5 | 2019 | 3612 | 0.110 |
Why?
|
Genome, Human | 2 | 2018 | 4445 | 0.110 |
Why?
|
DNA Damage | 1 | 2023 | 2462 | 0.110 |
Why?
|
Seminal Vesicles | 1 | 1993 | 101 | 0.110 |
Why?
|
Bone Neoplasms | 2 | 2016 | 2562 | 0.110 |
Why?
|
Erythrocytes | 2 | 2019 | 2393 | 0.110 |
Why?
|
Eicosanoids | 1 | 2015 | 284 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2017 | 748 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2006 | 2744 | 0.100 |
Why?
|
Blotting, Western | 3 | 2015 | 5018 | 0.100 |
Why?
|
Carrier Proteins | 5 | 2004 | 4911 | 0.100 |
Why?
|
Annexin A5 | 2 | 2015 | 102 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 7 | 2021 | 8105 | 0.100 |
Why?
|
Chitosan | 1 | 2014 | 138 | 0.100 |
Why?
|
Transplantation, Heterologous | 3 | 2013 | 2391 | 0.100 |
Why?
|
Porosity | 1 | 2013 | 347 | 0.100 |
Why?
|
Male | 17 | 2024 | 363740 | 0.100 |
Why?
|
Fluorescence | 1 | 2015 | 753 | 0.100 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22323 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 3110 | 0.100 |
Why?
|
Mutagenesis | 1 | 2016 | 1226 | 0.100 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2210 | 0.100 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1065 | 0.100 |
Why?
|
Intermediate Filament Proteins | 1 | 2012 | 261 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2019 | 3606 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2019 | 1405 | 0.090 |
Why?
|
Alanine | 1 | 2014 | 613 | 0.090 |
Why?
|
Eye Proteins | 1 | 1995 | 628 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2013 | 485 | 0.090 |
Why?
|
Thiazoles | 2 | 2017 | 1529 | 0.090 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9069 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1590 | 0.090 |
Why?
|
RNA | 1 | 2021 | 2716 | 0.090 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1697 | 0.090 |
Why?
|
Sulfones | 1 | 2013 | 447 | 0.090 |
Why?
|
HIV Infections | 2 | 2014 | 17530 | 0.090 |
Why?
|
Cell Membrane | 3 | 2006 | 3633 | 0.090 |
Why?
|
Flow Cytometry | 2 | 2013 | 5879 | 0.090 |
Why?
|
Models, Biological | 5 | 2013 | 9441 | 0.090 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 723 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 385 | 0.090 |
Why?
|
Paclitaxel | 1 | 2017 | 1726 | 0.080 |
Why?
|
Microfluidics | 1 | 2015 | 651 | 0.080 |
Why?
|
Female | 14 | 2024 | 396050 | 0.080 |
Why?
|
Multigene Family | 3 | 1998 | 1081 | 0.080 |
Why?
|
Biological Availability | 1 | 2010 | 388 | 0.080 |
Why?
|
Retinoblastoma Protein | 1 | 2013 | 666 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2013 | 1750 | 0.080 |
Why?
|
Binding, Competitive | 1 | 2010 | 1140 | 0.080 |
Why?
|
Hyperplasia | 1 | 2012 | 1146 | 0.080 |
Why?
|
Nephrons | 2 | 2017 | 165 | 0.080 |
Why?
|
Antigens | 1 | 1995 | 1438 | 0.080 |
Why?
|
Gene Targeting | 1 | 2012 | 841 | 0.080 |
Why?
|
Oncogenes | 2 | 2012 | 1233 | 0.080 |
Why?
|
Immunophenotyping | 1 | 2013 | 1865 | 0.080 |
Why?
|
HeLa Cells | 1 | 2015 | 3067 | 0.080 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1998 | 1837 | 0.080 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 1119 | 0.080 |
Why?
|
Transcription Factors | 3 | 2015 | 12122 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 997 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2878 | 0.080 |
Why?
|
Epitopes | 1 | 2014 | 2523 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2017 | 3404 | 0.070 |
Why?
|
Nervous System Diseases | 1 | 1998 | 1658 | 0.070 |
Why?
|
Chymotrypsin | 1 | 2008 | 136 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2010 | 871 | 0.070 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2008 | 220 | 0.070 |
Why?
|
Fluorescence Polarization | 1 | 2008 | 140 | 0.070 |
Why?
|
Benzamides | 1 | 2013 | 1376 | 0.070 |
Why?
|
Neurons | 3 | 2012 | 9521 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2794 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1995 | 1621 | 0.070 |
Why?
|
beta Catenin | 1 | 2012 | 1044 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2008 | 1678 | 0.070 |
Why?
|
Trypsin | 1 | 2008 | 487 | 0.070 |
Why?
|
Cell-Penetrating Peptides | 1 | 2007 | 43 | 0.070 |
Why?
|
Gene Expression | 3 | 2017 | 7581 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1764 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2971 | 0.070 |
Why?
|
Ganglia, Spinal | 2 | 2021 | 528 | 0.070 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1837 | 0.070 |
Why?
|
Cell Proliferation | 6 | 2019 | 10428 | 0.060 |
Why?
|
Androgens | 1 | 1993 | 1278 | 0.060 |
Why?
|
Time Factors | 3 | 2024 | 40109 | 0.060 |
Why?
|
Dextrans | 1 | 2008 | 570 | 0.060 |
Why?
|
Tacrolimus | 3 | 1998 | 754 | 0.060 |
Why?
|
Drosophila melanogaster | 1 | 2015 | 1721 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
Ultraviolet Rays | 1 | 2010 | 1099 | 0.060 |
Why?
|
Cell Cycle | 1 | 2013 | 2919 | 0.060 |
Why?
|
Prostate | 1 | 1993 | 1757 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2454 | 0.060 |
Why?
|
Leukemia | 1 | 2013 | 1523 | 0.060 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9548 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6219 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2023 | 5196 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3592 | 0.060 |
Why?
|
Mice, SCID | 2 | 2013 | 2627 | 0.060 |
Why?
|
Leukemic Infiltration | 1 | 2004 | 47 | 0.060 |
Why?
|
Regeneration | 1 | 1993 | 1516 | 0.060 |
Why?
|
Cell Division | 3 | 2004 | 4471 | 0.060 |
Why?
|
Calcium | 2 | 2008 | 5767 | 0.060 |
Why?
|
MicroRNAs | 2 | 2017 | 3785 | 0.050 |
Why?
|
Pandemics | 1 | 2024 | 8698 | 0.050 |
Why?
|
Organ Specificity | 2 | 1998 | 1964 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10845 | 0.050 |
Why?
|
Nanoparticles | 1 | 2014 | 1967 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3736 | 0.050 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1965 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 7073 | 0.050 |
Why?
|
Endosomes | 1 | 2004 | 522 | 0.050 |
Why?
|
Skin Tests | 1 | 2003 | 630 | 0.050 |
Why?
|
Proteins | 2 | 2011 | 5996 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 2 | 2018 | 697 | 0.050 |
Why?
|
Brain | 5 | 2000 | 27178 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7476 | 0.040 |
Why?
|
Insulin | 2 | 2021 | 6601 | 0.040 |
Why?
|
Gene Deletion | 2 | 2017 | 2667 | 0.040 |
Why?
|
Phosphorylation | 3 | 2021 | 8278 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2021 | 12767 | 0.040 |
Why?
|
Cell Nucleus | 3 | 2013 | 2864 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4391 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2003 | 645 | 0.040 |
Why?
|
PC12 Cells | 1 | 1999 | 316 | 0.040 |
Why?
|
Immune Evasion | 1 | 2023 | 377 | 0.040 |
Why?
|
Receptors, AMPA | 1 | 2000 | 334 | 0.040 |
Why?
|
Citric Acid Cycle | 1 | 2020 | 228 | 0.040 |
Why?
|
Subcellular Fractions | 2 | 1999 | 528 | 0.040 |
Why?
|
Nerve Growth Factor | 1 | 1999 | 155 | 0.040 |
Why?
|
Sperm Maturation | 1 | 1998 | 22 | 0.040 |
Why?
|
RNA Splicing | 1 | 2003 | 904 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 924 | 0.040 |
Why?
|
Cytoplasmic Granules | 1 | 2021 | 574 | 0.040 |
Why?
|
Conserved Sequence | 2 | 1998 | 1159 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2020 | 575 | 0.040 |
Why?
|
Chromatography, Affinity | 1 | 1998 | 521 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 1998 | 6061 | 0.030 |
Why?
|
Olfactory Pathways | 1 | 1998 | 131 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2018 | 461 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 1056 | 0.030 |
Why?
|
Methotrexate | 1 | 2003 | 1720 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 1995 | 11033 | 0.030 |
Why?
|
Cytoplasm | 2 | 2018 | 1497 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2019 | 6110 | 0.030 |
Why?
|
Anaphylaxis | 1 | 2003 | 738 | 0.030 |
Why?
|
Dipeptides | 1 | 2018 | 386 | 0.030 |
Why?
|
Transfection | 3 | 2017 | 5742 | 0.030 |
Why?
|
United States | 1 | 2024 | 72896 | 0.030 |
Why?
|
Sensory Receptor Cells | 1 | 2021 | 510 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2017 | 651 | 0.030 |
Why?
|
Phospholipase C beta | 1 | 1995 | 48 | 0.030 |
Why?
|
Thapsigargin | 1 | 1995 | 102 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1065 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2000 | 1178 | 0.030 |
Why?
|
Calcium-Transporting ATPases | 1 | 1995 | 122 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 3418 | 0.030 |
Why?
|
G-Protein-Coupled Receptor Kinase 3 | 1 | 1995 | 6 | 0.030 |
Why?
|
Islets of Langerhans | 1 | 2021 | 1349 | 0.030 |
Why?
|
Microscopy, Immunoelectron | 1 | 1995 | 315 | 0.030 |
Why?
|
Terpenes | 1 | 1995 | 102 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 2015 | 69 | 0.030 |
Why?
|
Gene Library | 1 | 1998 | 1066 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1999 | 2270 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 269 | 0.030 |
Why?
|
Homeostasis | 1 | 2006 | 3335 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2015 | 86 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 1995 | 284 | 0.030 |
Why?
|
Ions | 1 | 2015 | 255 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 2015 | 456 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18289 | 0.030 |
Why?
|
Aminopyridines | 1 | 2018 | 576 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 792 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1751 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1995 | 425 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2017 | 384 | 0.030 |
Why?
|
Thiophenes | 1 | 2018 | 570 | 0.030 |
Why?
|
Catalysis | 1 | 2015 | 770 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1998 | 900 | 0.030 |
Why?
|
Antioxidants | 1 | 2021 | 1670 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2017 | 616 | 0.030 |
Why?
|
Embryo, Nonmammalian | 1 | 2017 | 907 | 0.030 |
Why?
|
Epididymis | 1 | 1995 | 226 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 1998 | 4618 | 0.030 |
Why?
|
Blood Proteins | 1 | 1999 | 1186 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 1993 | 310 | 0.030 |
Why?
|
Xenopus laevis | 1 | 2017 | 965 | 0.030 |
Why?
|
DNA, Complementary | 3 | 2003 | 1984 | 0.030 |
Why?
|
Acetylation | 1 | 2015 | 1056 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1075 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1213 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2015 | 594 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2007 | 9594 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 798 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 137 | 0.020 |
Why?
|
Cricetinae | 1 | 1995 | 2412 | 0.020 |
Why?
|
Orchiectomy | 1 | 1993 | 465 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2162 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2020 | 2143 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 735 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 944 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1995 | 790 | 0.020 |
Why?
|
Species Specificity | 1 | 1995 | 2406 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 719 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1998 | 2087 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 1993 | 11092 | 0.020 |
Why?
|
Metabolomics | 1 | 2020 | 1668 | 0.020 |
Why?
|
Isoenzymes | 1 | 1995 | 1688 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 576 | 0.020 |
Why?
|
Dogs | 1 | 1995 | 3824 | 0.020 |
Why?
|
Phylogeny | 1 | 1998 | 2835 | 0.020 |
Why?
|
DNA Primers | 1 | 1995 | 2823 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 1998 | 1883 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 816 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1240 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3947 | 0.020 |
Why?
|
Prostatic Hyperplasia | 1 | 1993 | 514 | 0.020 |
Why?
|
Mammals | 1 | 1995 | 1125 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 3107 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4639 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2015 | 1673 | 0.020 |
Why?
|
RNA Interference | 1 | 2017 | 2827 | 0.020 |
Why?
|
Quinolines | 1 | 2014 | 770 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1164 | 0.020 |
Why?
|
Base Sequence | 2 | 1998 | 12402 | 0.020 |
Why?
|
Phosphoserine | 1 | 2008 | 203 | 0.020 |
Why?
|
Indoles | 1 | 2015 | 1832 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2213 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 1998 | 2677 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4752 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 292 | 0.020 |
Why?
|
Antibodies | 1 | 1995 | 2415 | 0.020 |
Why?
|
Zinc | 1 | 2011 | 675 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2487 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1884 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4133 | 0.020 |
Why?
|
Histidine | 1 | 2006 | 301 | 0.020 |
Why?
|
Fluorenes | 1 | 2007 | 160 | 0.020 |
Why?
|
Exons | 2 | 2003 | 2391 | 0.020 |
Why?
|
Hippocampus | 1 | 1998 | 3774 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3716 | 0.010 |
Why?
|
Protein Isoforms | 2 | 2000 | 1717 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 1108 | 0.010 |
Why?
|
Stem Cells | 1 | 2017 | 3539 | 0.010 |
Why?
|
Temperature | 1 | 2011 | 2226 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2011 | 2341 | 0.010 |
Why?
|
Ranitidine | 1 | 2003 | 34 | 0.010 |
Why?
|
Antipruritics | 1 | 2003 | 31 | 0.010 |
Why?
|
Cell Count | 1 | 2008 | 1823 | 0.010 |
Why?
|
Diphenhydramine | 1 | 2003 | 61 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13023 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2002 | 123 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 3034 | 0.010 |
Why?
|
Anti-Allergic Agents | 1 | 2003 | 153 | 0.010 |
Why?
|
Histamine H2 Antagonists | 1 | 2003 | 168 | 0.010 |
Why?
|
Urticaria | 1 | 2003 | 151 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2629 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4350 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3046 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1894 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1060 | 0.010 |
Why?
|
Thiazolidines | 1 | 2000 | 70 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2013 | 11643 | 0.010 |
Why?
|
Drug Eruptions | 1 | 2003 | 334 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5190 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20131 | 0.010 |
Why?
|
Pruritus | 1 | 2003 | 377 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2000 | 812 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1746 | 0.010 |
Why?
|
Two-Hybrid System Techniques | 1 | 2000 | 463 | 0.010 |
Why?
|
alpha Karyopherins | 1 | 1999 | 42 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2002 | 898 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16706 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1999 | 259 | 0.010 |
Why?
|
Aging | 1 | 1998 | 8731 | 0.010 |
Why?
|
G1 Phase | 1 | 1999 | 403 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1998 | 247 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1998 | 201 | 0.010 |
Why?
|
Models, Genetic | 1 | 2008 | 3447 | 0.010 |
Why?
|
3T3 Cells | 1 | 1999 | 1081 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 1999 | 192 | 0.010 |
Why?
|
Immunoblotting | 1 | 2000 | 1643 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 1998 | 370 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 223016 | 0.010 |
Why?
|
Adult | 2 | 2021 | 223055 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1993 | 6360 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88794 | 0.010 |
Why?
|
Chromosomes | 1 | 1998 | 578 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5786 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1999 | 1524 | 0.010 |
Why?
|
Polyenes | 1 | 1995 | 68 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 1560 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 1995 | 185 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6304 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59849 | 0.010 |
Why?
|
Blood Glucose | 1 | 2008 | 6422 | 0.010 |
Why?
|
Ion Channel Gating | 1 | 1995 | 428 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6960 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1998 | 2511 | 0.010 |
Why?
|
Cyclosporine | 1 | 1995 | 777 | 0.010 |
Why?
|
Synapses | 1 | 2000 | 1755 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1998 | 1888 | 0.010 |
Why?
|
Diet | 1 | 2008 | 8085 | 0.010 |
Why?
|
Muscle Proteins | 1 | 1995 | 1160 | 0.010 |
Why?
|
Sirolimus | 1 | 1995 | 1544 | 0.000 |
Why?
|
Cerebellum | 1 | 1995 | 1519 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171178 | 0.000 |
Why?
|